Our Science
Our Platform
ceDNA
ctLNP
Enzymatic Manufacturing
Our Scientific Presentations
Our Portfolio
An Overview
Liver
Retina
Early Research
Expansion Areas
Our Culture
Who We Are
Leadership
A Shared Vision
Investor Center
Join Us
Blog
News
Contact
Menu
In the news
Press Releases
November 3, 2022
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results
September 22, 2022
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
September 20, 2022
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
August 4, 2022
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
August 2, 2022
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
July 18, 2022
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
June 21, 2022
Generation Bio Announces Update to Its GMP Manufacturing Strategy
June 2, 2022
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
May 5, 2022
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
April 5, 2022
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
1
2
Next »
2021
December 14, 2021
Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program
November 10, 2021
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results
October 22, 2021
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
October 21, 2021
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit
October 15, 2021
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
August 11, 2021
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results
August 3, 2021
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021
July 14, 2021
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update
July 8, 2021
Generation Bio to Present at William Blair Biotech Focus Conference
June 9, 2021
Generation Bio to Present at the JMP Securities Life Sciences Conference
1
2
Next »
2020
November 10, 2020
Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results
October 5, 2020
Generation Bio to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
September 24, 2020
Generation Bio to Present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit
August 11, 2020
Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results
August 5, 2020
Generation Bio to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
July 22, 2020
Generation Bio Appoints Matthew Norkunas, M.D., MBA as Chief Financial Officer
June 16, 2020
Generation Bio Announces Closing of Initial Public Offering
June 11, 2020
Generation Bio Announces Pricing of Initial Public Offering
March 30, 2020
Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies Against Coronavirus That Causes COVID-19
January 10, 2020
Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia A and PKU
1
2
Next »
2019
October 29, 2019
Generation Bio Welcomes Steven Dowdy, Ph.D., to its Scientific Advisory Board
June 25, 2019
Generation Bio Appoints Katherine Fitzgerald, Ph.D., to its Scientific Advisory Board
May 31, 2019
Generation Bio to Present at Jefferies 2019 Healthcare Conference
March 8, 2019
Generation Bio to Present at the Cowen & Company 39th Annual Health Care Conference
January 4, 2019
Generation Bio to Present at 37th Annual J.P. Morgan Healthcare Conference
2018
December 17, 2018
Generation Bio to Appoint Tom Graney as Chief Financial Officer
November 19, 2018
Generation Bio to Present at the Evercore ISI Healthcare Conference
November 5, 2018
Generation Bio Appoints Antoinette Paone as Head of Regulatory Affairs
October 4, 2018
Generation Bio Appoints Dr. Richard Thompson to its Scientific Advisory Board
July 31, 2018
Generation Bio Appoints Charles Rowland to its Board of Directors
June 7, 2018
Generation Bio Appoints Jeff Jonas M.D. to its Board of Directors
June 5, 2018
Generation Bio to Present at Jefferies 2018 Global Healthcare Conference
May 8, 2018
Generation Bio Expands Leadership Team with Appointment of Sara Den Besten as Head of Human Resources
April 9, 2018
Generation Bio Strengthens Leadership Team with Appointment of Will McCarthy as Chief Business Officer and Jennifer Elliott, Ph.D., J.D., as Head of Legal Affairs and Intellectual Property
February 27, 2018
Generation Bio Announces $100 Million Series B Financing to Advance GeneWaveTM Platform for Re-Dosable Gene Therapy
1
2
Next »
Twitter
Tweets by GenerationBio
Media Contact
media@generationbio.com
Investor Relations Contact
investors@generationbio.com
Follow us on Twitter
Follow us on Linkedin
close
arrow-circle-o-down
arrow-down
bars
ellipsis-v
cross
